Comparison of irisin hormone expression between thyroid cancer tissues and oncocytic variant cells

References

• Nguyen QT, Lee EJ, Huang MG, Park YI, Khullar A, Plodkowski RA. Diagnosis and treatment of patients with thyroid cancer. Am Health Drug Benefits. 2015;8(1):30–40.
   PubMed Web of Science ®Google Scholar
• Tumino D, Frasca F, Newbold K. Updates on the management of advanced, metastatic, and radioiodine refractory differentiated thyroid cancer. Front Endocrinol (Lausanne). 2017;8:312. doi:10.3389/fendo.2017.0031229209273
   PubMed Web of Science ®Google Scholar
• Udelsman R, Zhang Y. The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds. Thyroid. 2014;24(3):472–479. doi:10.1089/thy.2013.025723937391
   PubMed Web of Science ®Google Scholar
• Lamartina L, Grani G, Durante C, Filetti S. Recent advances in managing differentiated thyroid cancer. F1000Research. 2018;7:86.29399330
   PubMedGoogle Scholar
• WHO. Classification of tumours of the thyroid gland (2018). Available from: http://www.pathologyoutlines.com/imgau/thyroid/thyroidwhoBychkov01.jpg. Accessed January 2, 2019.
   Google Scholar
• Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014;94(2):355–382.24692351
   PubMed Web of Science ®Google Scholar
• Gurgul E, Kasprzak A, Blaszczyk A, et al. Ghrelin and obestatin in thyroid gland – immunohistochemical expression in nodular goiter, papillary and medullary cancer. Folia Histochem Cytobiol. 2015;53(1):19–25.25765090
   PubMed Web of Science ®Google Scholar
• Karaoglu A, Aydin S, Dagli AF, et al. Expression of obestatin and ghrelin in papillary thyroid carcinoma. Mol Cell Biochem. 2009;323(1–2):113–118.19039650
   PubMed Web of Science ®Google Scholar
• Zhang YF, Wang HN, Hong TP. Ghrelin expression in the tissues of different thyroid diseases. Beijing Da Xue Xue Bao Yi Xue Ban. 2006;38(2):193–196.16617365
   PubMedGoogle Scholar
• Pisarev MA. Interrelationships between the pancreas and the thyroid. Curr Opin Endocrinol Diabetes Obes. 2010;17(5):437–439. doi:10.1097/MED.0b013e32833e075020717019
   PubMedGoogle Scholar
• Di Pasquale M, Rothstein JL, Palazzo JP. Pathologic features of Hashimoto’s-associated papillary thyroid carcinomas. Hum Pathol. 2001;32(1):24–30. doi:10.1053/hupa.2001.2113811172291
   PubMed Web of Science ®Google Scholar
• Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463–468. doi:10.1038/nature1077722237023
   PubMed Web of Science ®Google Scholar
• Aydin S, Kuloglu T, Aydin S, et al. A comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissues. Peptides. 2014;61:130–136. doi:10.1016/j.peptides.2014.09.01425261800
   PubMed Web of Science ®Google Scholar
• Aydin S. Three new players in energy regulation: preptin, adropin and irisin. Peptides. 2014;56:94–110. doi:10.1016/j.peptides.2014.03.02124721335
   PubMed Web of Science ®Google Scholar
• Wang P, Ma HH, Hou XZ, Song LL, Song XL, Zhang JF. Reduced plasma level of irisin in first trimester as a risk factor for the development of gestational diabetes mellitus. Diabetes Res Clin Pract. 2018;142:130–138. doi:10.1016/j.diabres.2018.05.03829852234
   PubMed Web of Science ®Google Scholar
• Zhao L, Li J, Li ZL, Yang J, Li ML, Wang GL. Circulating irisin is lower in gestational diabetes mellitus. Endocr J. 2015;62(10):921–926. doi:10.1507/endocrj.EJ15-023026228794
   PubMed Web of Science ®Google Scholar
• Gizaw M, Anandakumar P, Debela T. A review on the role of irisin in insulin resistance and Type 2 diabetes mellitus. J Pharmacopuncture. 2017;20(4):235–242. doi:10.3831/KPI.2017.20.02930151293
   PubMed Web of Science ®Google Scholar
• Park MJ, Kim DI, Choi JH, Heo YR, Park SH. New role of irisin in hepatocytes: the protective effect of hepatic steatosis in vitro. Cell Signal. 2015;27(9):1831–1839. doi:10.1016/j.cellsig.2015.04.01025917316
   PubMed Web of Science ®Google Scholar
• Aydin S, Kuloglu T, Ozercan MR, et al. Irisin immunohistochemistry in gastrointestinal system cancers. Biotech Histochem. 2016;91(4):242–250. doi:10.3109/10520295.2015.113698826963139
   PubMed Web of Science ®Google Scholar
• Kuloglu T, Celik O, Aydin S, et al. Irisin immunostaining characteristics of breast and ovarian cancer cells. Cell Mol Biol (Noisy-Le-Grand). 2016;62(8):40–44.27545213
   PubMed Web of Science ®Google Scholar
• Liu J, Song N, Huang Y, Chen Y. Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway. Sci Rep. 2018;8(1):15247. doi:10.1038/s41598-018-33229-w30323244
   PubMedGoogle Scholar
• Tekin S, Erden Y, Sandal S, Yilmaz B. Is irisin an anticarcinogenic peptide? Med-Sci. 2015;4:2172–2180. doi:10.5455/medscience.2014.03.8210
   Google Scholar
• Manole E, Ceafalan LC, Popescu BO, Dumitru C, Bastian AE. Myokines as possible therapeutic targets in cancer cachexia. J Immunol Res. 2018;2018:8260742. doi:10.1155/2018/826074230426026
   PubMed Web of Science ®Google Scholar
• Aydin S. Is irisin a decisive protein in cancer cachexia and death of cancer cells? Eur Rev Med Pharmacol Sci. 2016;20(18):3727–3729.27735050
   PubMedGoogle Scholar
• Zybek-Kocik A, Sawicka-Gutaj N, Szczepanek-Parulska E, et al. The association between irisin and muscle metabolism in different thyroid disorders. Clin Endocrinol (Oxf). 2018;88(3):460–467. doi:10.1111/cen.1352729197093
   PubMed Web of Science ®Google Scholar
• Moon HS, Mantzoros CS. Regulation of cell proliferation and malignant potential by irisin in endometrial, colon, thyroid and esophageal cancer cell lines. Metabolism. 2014;63(2):188–193. doi:10.1016/j.metabol.2013.10.00524268368
   PubMed Web of Science ®Google Scholar
• Brenmoehl J, Albrecht E, Komolka K, et al. Irisin is elevated in skeletal muscle and serum of mice immediately after acute exercise. Int J Biol Sci. 2014;10(3):338–349. doi:10.7150/ijbs.797224644429
   PubMed Web of Science ®Google Scholar
• Silva JE. Thyroid hormone control of thermogenesis and energy balance. Thyroid. 1995;5(6):481–492. doi:10.1089/thy.1995.5.4818808101
   PubMed Web of Science ®Google Scholar
• Repasky EA, Evans SS, Dewhirst MW. Temperature matters! And why it should matter to tumor immunologists. Cancer Immunol Res. 2013;1(4):210–216. doi:10.1158/2326-6066.CIR-13-011824490177
   PubMed Web of Science ®Google Scholar
• Haymart MR, Esfandiari NH, Stang MT, Sosa JA. Controversies in the management of low-risk differentiated thyroid cancer. Endocr Rev. 2017;38(4):351–378. doi:10.1210/er.2017-0006728633444
   PubMed Web of Science ®Google Scholar
• Katoh H, Yamashita K, Enomoto T, Watanabe M. Classification and general considerations of thyroid cancer. Ann Clin Pathol. 2015;3(1):1045.
   Google Scholar
• Kakudo E, Satoh S, Inomata K, Kagiya T, Yamashita H, Lai CR. Papillary thyroid neoplasms in the 4th edition WHO classification of tumors of endocrine organs: neoplasms with papillary thyroid carcinoma-type nuclear features. JBCM. 2018;7(1):21–35.
   Google Scholar
• Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (abc) in immunoperoxidase techniques-a comparison between ABC and unlabeled antibody (pap) procedures. J Histochem Cytochem. 1981;29:577–580. doi:10.1177/29.4.61666616166661
   PubMed Web of Science ®Google Scholar
• Chen Z, Wang T, Cai L, et al. Clinicopathological significance of non-small cell lung cancer with high prevalence of Oct- 4 tumor cells. J Exp Clin Cancer Res. 2012;31:10. doi:10.1186/1756-9966-31-9522300949
   PubMed Web of Science ®Google Scholar
• Aydin S, Ozercan IH, Dagli F, et al. Ghrelin immunohistochemistry of gastric adenocarcinoma and mucoepidermoid carcinoma of salivary gland. Biotech Histochem. 2005;80(3–4):163–168. doi:10.1080/1052029050038784716298902
   PubMed Web of Science ®Google Scholar
• Aydin S, Kuloglu T, Aydin S, et al. Cardiac, skeletal muscle and serum irisin responses to with or without water exercise in young and old male rats: cardiac muscle produces more irisin than skeletal muscle. Peptides. 2014;52:68–73. doi:10.1016/j.peptides.2013.11.02424345335
   PubMed Web of Science ®Google Scholar
• Brehar AC, Brehar FM, Bulgar AC, Dumitrache C. Genetic and epigenetic alterations in differentiated thyroid carcinoma. J Med Life. 2013;6(4):403–408.24868250
   PubMedGoogle Scholar
• Fröhlich E, Wahl R. Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases. Front Immunol. 2017;8:521.28536577
   PubMed Web of Science ®Google Scholar
• Mazur-Bialy AI, Pocheć E, Zarawski M. Anti-inflammatory properties of irisin, mediator of physical activity, are connected with TLR4/MyD88 signaling pathway activation. Int J Mol Sci. 2017;18(4):E701.28346354
   PubMed Web of Science ®Google Scholar
• Uc ZA, Gorar S, Mizrak S, Gullu S. Irisin levels increase after treatment in patients with newly diagnosed hashimoto thyroiditis. J Endocrinol Invest. 2019;42(2)175–181.29777516
   PubMed Web of Science ®Google Scholar
• Bakal U, Aydin S, Sarac M, et al. Serum, Saliva, and Urine Irisin with and without acute appendicitis and abdominal pain. Biochem Insights. 2016;9:11–17.27330302
   PubMedGoogle Scholar
• Cannon J. The significance of hurthle cells in thyroid disease. Oncologist. 2011;16(10):1380–1387.21964000
   PubMed Web of Science ®Google Scholar
• Picard M, McEwen BS, Epel ES, Sandi C. An energetic view of stress: focus on mitochondria. Front Neuroendocrinol. 2018;49:72–85.29339091
   PubMed Web of Science ®Google Scholar
• Ost M, Keipert S, Klaus S. Targeted mitochondrial uncoupling beyond UCP1 – the fine line between death and metabolic health. Biochimie. 2017;134:77–85.27916644
   PubMed Web of Science ®Google Scholar
• Asa SL. My approach to oncocytic tumours of the thyroid. J Clin Pathol. 2004;57(3):225–232.14990587
   PubMed Web of Science ®Google Scholar
• Zhang J, Yu W, Ryu SW, et al. Cardiolipins are biomarkers of mitochondria-rich thyroid oncocytic tumors. Cancer Res. 2016;76(22):6588–6597.27659048
   PubMed Web of Science ®Google Scholar
• JanovitzJustine T, Barletta A. Clinically relevant prognostic parameters in differentiated thyroid carcinoma. Endocr Pathol. 2018;29(4):357–364.30238434
   PubMed Web of Science ®Google Scholar
• Liberti MV, Locasale JW. The warburg effect: how does it benefit cancer cells? Trends Biochem Sci. 2016;41(3):211–218.26778478
   PubMed Web of Science ®Google Scholar
• Aboelnaga EM, Ahmed RA. Difference between papillary and follicular thyroid carcinoma outcomes: an experience from Egyptian institution. Cancer Biol Med. 2015;12(1):53–59.25859412
   PubMed Web of Science ®Google Scholar
• Liu TR, Xiao ZW, Xu HN, et al. Treatment and prognosis of anaplastic thyroid carcinoma: a clinical study of 50 cases. PLoS One. 2016;11(10):e0164840.27760217
   PubMed Web of Science ®Google Scholar
• Gilbert A, Czarkowska-Paczek B, Deptała A. Physical activity in prevention and treatment of colon cancer. Przegl Lek. 2013;70:969–972.24697040
   PubMedGoogle Scholar
• Wissig SL. The anatomy of secretion in the follicular cells of the thyroid gland. I. The fine structure of the gland in the normal rat. J Biophys Biochem Cytol. 1960;7:419–432.13845420
   PubMedGoogle Scholar
• Chen C, Xie Z, Shen Y, Xia SF. The roles of thyroid and thyroid hormone in pancreas: physiology and pathology. Int J Endocrinol. 2018;2018:2861034.30013597
   PubMed Web of Science ®Google Scholar